Pediatrix Medical Gross Margin 2010-2025 | MD
Current and historical gross margin for Pediatrix Medical (MD) over the last 10 years. The current gross profit margin for Pediatrix Medical as of March 31, 2025 is %.
| Pediatrix Medical Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $1.98B | $0.46B | 23.44% |
| 2024-12-31 | $2.01B | $0.46B | 22.61% |
| 2024-09-30 | $2.01B | $0.43B | 21.29% |
| 2024-06-30 | $2.00B | $0.42B | 20.83% |
| 2024-03-31 | $2.00B | $0.42B | 20.91% |
| 2023-12-31 | $2.00B | $0.42B | 21.10% |
| 2023-09-30 | $2.01B | $0.44B | 21.66% |
| 2023-06-30 | $2.00B | $0.44B | 22.24% |
| 2023-03-31 | $1.98B | $0.45B | 22.92% |
| 2022-12-31 | $1.97B | $0.47B | 23.68% |
| 2022-09-30 | $1.96B | $0.49B | 24.99% |
| 2022-06-30 | $1.96B | $0.51B | 26.12% |
| 2022-03-31 | $1.95B | $0.52B | 26.66% |
| 2021-12-31 | $1.91B | $0.51B | 26.88% |
| 2021-09-30 | $1.83B | $0.48B | 26.45% |
| 2021-06-30 | $1.80B | $0.47B | 26.36% |
| 2021-03-31 | $1.74B | $0.45B | 26.09% |
| 2020-12-31 | $1.73B | $0.45B | 25.89% |
| 2020-09-30 | $1.78B | $0.48B | 26.80% |
| 2020-06-30 | $1.77B | $0.48B | 27.06% |
| 2020-03-31 | $1.92B | $0.54B | 28.29% |
| 2019-12-31 | $2.33B | $0.65B | 27.73% |
| 2019-09-30 | $1.02B | $0.33B | 32.03% |
| 2019-06-30 | $1.42B | $0.42B | 29.55% |
| 2019-03-31 | $1.72B | $0.49B | 28.34% |
| 2018-12-31 | $1.72B | $0.51B | 29.29% |
| 2018-09-30 | $3.27B | $0.87B | 26.52% |
| 2018-06-30 | $3.29B | $0.90B | 27.30% |
| 2018-03-31 | $3.27B | $0.91B | 27.70% |
| 2017-12-31 | $3.25B | $0.92B | 28.27% |
| 2017-09-30 | $3.38B | $1.00B | 29.71% |
| 2017-06-30 | $3.34B | $1.03B | 30.74% |
| 2017-03-31 | $3.27B | $1.04B | 31.68% |
| 2016-12-31 | $3.18B | $1.03B | 32.47% |
| 2016-09-30 | $3.10B | $1.02B | 33.09% |
| 2016-06-30 | $2.99B | $1.00B | 33.36% |
| 2016-03-31 | $2.89B | $0.97B | 33.38% |
| 2015-12-31 | $2.78B | $0.93B | 33.38% |
| 2015-09-30 | $2.69B | $0.90B | 33.32% |
| 2015-06-30 | $2.59B | $0.86B | 33.08% |
| 2015-03-31 | $2.51B | $0.83B | 33.03% |
| 2014-12-31 | $2.44B | $0.81B | 33.07% |
| 2014-09-30 | $2.36B | $0.77B | 32.85% |
| 2014-06-30 | $2.28B | $0.75B | 32.92% |
| 2014-03-31 | $2.22B | $0.73B | 32.88% |
| 2013-12-31 | $2.15B | $0.71B | 32.96% |
| 2013-09-30 | $2.06B | $0.68B | 33.09% |
| 2013-06-30 | $1.98B | $0.66B | 33.20% |
| 2013-03-31 | $1.90B | $0.63B | 33.42% |
| 2012-12-31 | $1.82B | $0.61B | 33.74% |
| 2012-09-30 | $1.75B | $0.59B | 33.92% |
| 2012-06-30 | $1.69B | $0.58B | 34.10% |
| 2012-03-31 | $1.63B | $0.56B | 34.44% |
| 2011-12-31 | $1.59B | $0.55B | 34.70% |
| 2011-09-30 | $1.55B | $0.54B | 34.82% |
| 2011-06-30 | $1.49B | $0.52B | 34.87% |
| 2011-03-31 | $1.45B | $0.51B | 34.83% |
| 2010-12-31 | $1.40B | $0.49B | 34.83% |
| 2010-09-30 | $1.37B | $0.48B | 34.92% |
| 2010-06-30 | $1.35B | $0.47B | 35.07% |
| 2010-03-31 | $1.32B | $0.46B | 35.00% |
| 2009-12-31 | $1.29B | $0.45B | 35.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.283B | $2.013B |
| Pediatrix Medical Group Inc. is a national medical group comprised of physician services practicing under the Pediatrix(R) brand. It provides services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Pediatrix Medical Group Inc., formerly known as Mednax Inc., is based in FORT LAUDERDALE, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.350B | 26.32 |
| Elevance Health (ELV) | United States | $91.117B | 11.76 |
| CVS Health (CVS) | United States | $79.102B | 9.83 |
| Cencora (COR) | United States | $56.251B | 19.57 |
| DiDi Global (DIDIY) | China | $21.979B | 33.36 |
| Natera (NTRA) | United States | $20.836B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.822B | 13.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.604B | 0.00 |
| CochLear (CHEOY) | Australia | $11.282B | 0.00 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| ICON (ICLR) | Ireland | $10.630B | 9.88 |
| Viatris (VTRS) | United States | $10.375B | 3.56 |
| Doximity (DOCS) | United States | $9.813B | 45.70 |
| Avantor (AVTR) | United States | $9.138B | 13.28 |
| Medpace Holdings (MEDP) | United States | $8.785B | 23.33 |
| HealthEquity (HQY) | United States | $8.497B | 41.80 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.924B | 13.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.257B | 39.40 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| Sotera Health (SHC) | United States | $3.633B | 20.65 |
| Alignment Healthcare (ALHC) | United States | $3.122B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.068B | 39.90 |
| Concentras Parent (CON) | United States | $2.912B | 16.83 |
| Organon (OGN) | United States | $2.350B | 2.50 |
| Ardent Health Partners (ARDT) | United States | $2.204B | 9.40 |
| GeneDx Holdings (WGS) | United States | $1.949B | 75.07 |
| Progyny (PGNY) | United States | $1.912B | 42.08 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| PACS (PACS) | United States | $1.647B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.414B | 28.29 |
| Teladoc Health (TDOC) | United States | $1.319B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.046B | 0.00 | |
| Agilon Health (AGL) | United States | $1.014B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 15.25 |
| Nutex Health (NUTX) | United States | $0.972B | 14.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.869B | 8.13 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.702B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.33 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.487B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.370B | 0.00 |
| SBC Medicals (SBC) | United States | $0.352B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.150B | 24.50 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| KindlyMD (KDLY) | United States | $0.078B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |